“I’m proud to announce that the Global Spine Congress (GSC) 2026 has received a record-breaking number of abstract submissions, reflecting our continued growth as the world’s leading meeting for spine specialists.
Each abstract represents the dedication of our global community—researchers, surgeons, and clinicians—committed to advancing spine research, education, and patient care. This achievement highlights how GSC continues to serve as a global platform for innovation and scientific collaboration in spine surgery.
Thank you to all who submitted and to the dedicated teams supporting this success. Together, we’re shaping a world-class scientific program that will inspire progress, connection, and discovery at GSC 2026 in Istanbul.”
Jeffrey Wang, GSC congress chairperson
| Degenerative—lumbar | 294 | 11.0% |
| Minimally invasive spine surgery | 281 | 10.5% |
| Tumors | 205 | 7.7% |
| Deformity—thoracolumbar (Adult) | 188 | 7.1% |
| Deformity—thoracolumbar (Adolescent) | 172 | 6.5% |
| Degenerative—cervical | 159 | 6.0% |
| Surgical complications | 157 | 5.9% |
| Novel technologies | 140 | 5.3% |
| Trauma—thoracolumbar | 122 | 4.6% |
| Infections | 114 | 4.3% |
| Trauma—cervical | 83 | 3.1% |
| Diagnostics | 79 | 3.0% |
| Epidemiology | 75 | 2.8% |
| Imaging | 73 | 2.7% |
| Basic science | 72 | 2.7% |
| Biomechanics | 71 | 2.7% |
| Nonoperative clinical treatments | 64 | 2.4% |
| Deformity—cervical | 54 | 2.0% |
| Disc degeneration | 47 | 1.8% |
| Arthroplasty—cervical | 44 | 1.7% |
| Navigation | 44 | 1.7% |
| Trauma—other | 44 | 1.7% |
| Medical economics | 33 | 1.2% |
| Arthroplasty—lumbar | 31 | 1.2% |
| Spine biologics | 18 | 0.7% |